Colinz Laboratories Ltd

NSE: COLINZ · BSE: 531210 · Pharmaceuticals & Biotechnology · 4 announcements

Share price: ₹76.20
Market cap: ₹19.20 Cr
Revenue (annual): ₹6.14 Cr
Net profit (annual): ₹0.51 Cr
P/E (TTM): 6.9×Sector 50.4×
Promoter holding: 50.60%-15.40% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Open Offer 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

4 announcements

22 Sep 2026 17:39 IST BSE

Annual General Meeting

Colinz Laboratories Annual General Meeting

Colinz Laboratories held its 40th Annual General Meeting on September 22, 2026, where shareholders considered financial statements and director appointments.

Read the filing ↗

4 Sep 2026 19:34 IST BSE

Open Offer

Colinz Laboratories Open Offer: ₹3.54 Cr

Colinz Laboratories Ltd issued a Post Offer Advertisement for an Open Offer. The offer closed with only 6 shares tendered out of a proposed 6,54,966 shares.

Value: ₹3.54 Cr

Read the filing ↗

30 Jul 2026 17:43 IST BSE

Financial Results

Colinz Laboratories Q1 FY27 Results: Net Profit ₹2.4 Cr, Up 2300.0% YoY

Colinz Laboratories Ltd reported revenue from operations of ₹1.2 Cr (-25.0% YoY) and net profit of ₹2.4 Cr (+2300.0% YoY) for Q1 FY27.

Key figure: Net profit ₹2.4 Cr · +2300.0% YoY

Open full results → Read the filing ↗

29 Apr 2026 17:32 IST BSE

Financial Results

Colinz Laboratories Q4 FY26 Results: Net Profit ₹0.2 Cr, Up 0.0% YoY

Colinz Laboratories Ltd reported revenue from operations of ₹1.7 Cr (+13.3% YoY) and net profit of ₹0.2 Cr (+0.0% YoY) for Q4 FY26.

Key figure: Net profit ₹0.2 Cr · +0.0% YoY

Open full results → Read the filing ↗